STUB1 and COVID-19: To date, four studies have explored the association of CHIP with COVID-19 severity defined by different outcomes, such as hospitalization, hypoxia, intubation and/or death; but only the work published by Bolton and colleagues in 2020 reported an increased risk of severe outcome [6–9].